InsidersTradesSigma
Follow the 通策医疗 share price and the full insider trade history of the company, a publicly traded company based in China. Shares are quoted on the CN market, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 通策医疗 has logged 13 reports. Market capitalisation: €15.9bn. The latest transaction was disclosed on 10 June 2026 (Purchase). Among the most active insiders: 吕建明. All data is free.
13
Insider Decl.
n/a
Thresholds
€3m
13 ops.
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate 通策医疗 Hold (neutral), based on 8 analysts. Average price target: CN¥44.02.
10Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 10,479 of 29,064 companies
58.5
score / 100
Value47
Quality70
FCF yld3.6%
Earn yld3.2%
EV/EBITDA17.9x
ROE16%
Gross mgn39%
Net mgn17%
Debt/EBITDA1.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 10 June 2026
Declarations13 total
13 of 13 declarations
Acerca de 通策医疗
通策医疗 es una empresa especializada en el sector de la salud y farmacéutico, que cotiza en el mercado XSHG. Se centra en el desarrollo y la provisión de servicios médicos innovadores.